Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144,460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant α-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus.
Huang Z, Wan X, Liu J, Deng W, Chen A, Liu L, Liu J, Wei G, Li H, Fang D, Li Y. Huang Z, et al. Among authors: liu j, liu l. Diabetes Technol Ther. 2013 Oct;15(10):859-69. doi: 10.1089/dia.2013.0013. Epub 2013 Aug 30. Diabetes Technol Ther. 2013. PMID: 23991629 Free PMC article. Clinical Trial.
Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study.
Ke W, Liu L, Liu J, Chen A, Deng W, Zhang P, Cao X, Liao Z, Xiao H, Liu J, Li Y. Ke W, et al. Among authors: liu j, liu l. J Diabetes Res. 2016;2016:6839735. doi: 10.1155/2016/6839735. Epub 2015 Nov 10. J Diabetes Res. 2016. PMID: 26640805 Free PMC article. Clinical Trial.
144,460 results
You have reached the last available page of results. Please see the User Guide for more information.